Initiation of more effective contraception occurred more often among patients who were seen by a volunteer reproductive health educator during routine visits at a resident obstetrics and gynecology clinic, according to a study published in Maternal and Child Health Journal.
Women with HIV are no more vulnerable to menopause-related cognitive declines compared to other women, according to a longitudinal cohort study in the journal Menopause.
A retrospective study in the journal Obstetrics & Gynecology and Reproductive Health has concluded that total laparoscopic retrograde hysterectomy (TLreH) for severe endometriosis with obliterated cul-de-sac is both feasible and safe.
In this video, Senior Editor Angie DeRosa interviews Emily Adhikari, MD, on questions or concerns she and colleagues are hearing from patients surrounding the COVID-19 vaccine.
In response to the coronavirus disease 2019 pandemic, many U.S. family planning providers have started offering telemedicine services.
What to look for this week on Contemporary OB/GYN®
It was a very busy week for the Contemporary OB/GYN team.
In a recent survey, Medical Economics® asked their audience what challenges they see for 2021. Hiring and retaining medical staff landed among the top five issues.
This FAQ is a printable reference for ob/gyns. It features information on the COVID-19 vaccines, as well as frequently asked questions and answers for ob/gyns to use when counseling patients.
The recommendations address the role of physicians as vaccinators.
The January issue of Contemporary OB/GYN® featured a peer-reviewed article on syphilis in pregnancy.
Since radical hysterectomy does not improve survival, the procedure should be replaced with definitive chemoradiation, according to the ABRAX study published in the European Journal of Cancer.
While no difference was shown in disease-free survival rates between surgical and non-surgical staging methods, laparoscopy benefits patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. Surgical staging also has a cancer-specific survival benefit, according to a study published in the International Journal of Gynecological Cancers.
With coronavirus disease 2019 limiting the availability of health resources, research using a comprehensive review and expert opinion has set pandemic treatment protocols for gynecological cancers.
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
What to look for this week on Contemporary OB/GYN®
It was a very busy week for the Contemporary OB/GYN® team.
The Society for Academic Specialists in General Obstetrics and Gynecology (SASGOG) recently announced its call for abstracts for the 2021 Annual Meeting. The meeting will be held virtually on April 9, 2021 from 1 p.m. to 5:30 p.m. EST.
In honor of Cervical Cancer Awareness month, Contemporary OB/GYN® will publish weekly slideshows with factual information, statistics, and more.
The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Peer-reviewed
Diagnosis and treatment of “the great imitator” that has resurged.
Peer-reviewed
An effective option for refractory cervical insufficiency.
Cervical Cancer Awareness Month
“Reaching these women is critical to reduce cervical cancer rates.”
The Society for Maternal-Fetal Medicine’s (SMFM) 2021 Annual Pregnancy Meeting will be held virtually throughout the month of January, with core meeting activities taking place Jan. 25-30. SMFM’s President, Judette Louis, MD, MPH, and Program Committee Chair, Cynthia Gyamfi-Bannerman, MD, MSc, tell readers what they can expect in the new online format.
With this first issue of 2021, you may notice something different on the cover and on the banner of our website. This special design features a teal ribbon wrap and related content for cervical cancer content.
What to look for this week on Contemporary OB/GYN®
It was a very busy week for the Contemporary OB/GYN® team.
Medical World News
Pembrolizumab plus lenvatinib induced a statistically significant and clinically meaningful improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with advanced endometrial cancer after prior systemic therapy in the phase 3 KEYNOTE-775/Study 309 trial.
Join Senior Editor Angie DeRosa with a look back at this year's cover designs and feature stories.